HONG KONG, 23rd August, 2016 – Abbott Informatics’ Manager of Global Strategy,
Mr. Randy Hice, joins Cedrus Investments’ (“Cedrus”) Life Sciences Advisory
Board.
Randy is recognized worldwide as a leading authority in laboratory
informatics, specifically focused on complex, large-scale implementation of
Laboratory Information Management Systems (LIMS), Laboratory Information Systems
(LIS), Electronic Laboratory Notebook (ELN), and sophisticated Cloud
architectures. He has been working in the field of laboratory automation since
1984, first as a programmer/analyst at Digital Equipment Corporation, then as a
Principal with Laboratory Expertise Center. In 1989, he pioneered Laboratory
Workflow Analysis as a methodology for system selection, project planning,
harmonization, and system design. With STARLIMS Corporation purchasing
Laboratory Expertise Center in 2008 and STARLIMS being acquired subsequently, he
now serves as the Manager of Global Strategy for Abbott Informatics where his
focus is on complex business analysis, harmonization, inter-operational
platforms, Clinical LIS, and Cloud Computing. He is also responsible for
analyzing global market potential, demand and profitability for complex
informatics systems.
Randy has developed global laboratory automation and harmonization strategies
for leading pharmaceutical, biotechnology, medical device, and Contract Research
Organization (CRO) companies, identifying opportunities to share and utilize
critical laboratory data across corporate locations in Europe, Asia, and the
U.S.
As the manager of the Strategic Consulting group of Abbott Informatics, Randy
assumed the visionary role of leading the Cloud Services initiative in which he
developed service offerings in Infrastructure as a Service (IaaS) and Software
as a Service (SaaS) areas to meet the growing demand for Cloud applications.
Randy is the most published author in the world of laboratory automation and
workflow analysis, and has served as the monthly Laboratory Automation editor
for the Scientific Computing magazine since 1996. He has also contributed to
American Pharmaceutical Review and American Laboratory.
Cedrus Investments has been investing in and providing financial advisory
services to the life sciences industry for over a decade. In recent years, the
firm has been assisting Australian and European life sciences companies to
increase their visibility with a broad pool of institutional investors in the
Greater China region. At the same time, Cedrus also helps Chinese
biopharmaceutical companies and investors to identify valuable overseas
investment opportunities.
Mr. Hice said, “I am delighted to join the Cedrus’
Life Sciences Advisory Board. I look forward to sharing my expertise and
experience with the Cedrus’ team to identify and evaluate exciting investment
opportunities.”
Mr.
Rani Jarkas, Chairman of Cedrus Investments extended his welcome and said,
“We are excited to have Mr. Randy Hice joined our Life Sciences Advisory Board.
As a reputable figure in laboratory informatics, Randy is an ideal addition to
the board. His decades of experience and in-depth knowledge will be invaluable
to both Cedrus’ direct investments and its investor clients from across the
globe. In addition, Randy’s global connections and business development skills
in the industry also solidify Cedrus’ unique position in identifying early
opportunities to maximize investment returns.”
No comments:
Post a Comment